Last updated on December 2018

Dysport Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2

Brief description of study

The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport doses (600 units [U] and 800 U), compared to placebo in reducing urinary incontinence (UI) in adult subjects treated for neurogenic detrusor overactivity (NDO) due to spinal cord injury (SCI) or multiple sclerosis (MS).

Clinical Study Identifier: NCT02660359

Contact Investigators or Research Sites near you

Start Over

Ipsen Recruitment Enquiries

Hospital Universitario Infanta Sof a
San Sebastián de Los Reyes, Spain